A molecular key for delaying the progression of multiple sclerosis is found

multiple sclerosis
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

Multiple sclerosis (MS) is an autoimmune disease that attacks and destroys the myelin sheath that insulates nerve cells. Current treatment is based on modulating the activity of the immune system or preventing immune cells from accessing the central nervous system and damaging it. These therapies are effective in the early phases of the disease, but they do not prevent its advance and the associated progressive functional deterioration.

During the progressive phase of the disease, the microglial cells in the brain are the main cause of the chronic inflammation responsible for neurological deterioration. These microglial cells are the brain's sentries, reacting when faced with damage or infection. This reaction, which is in principle beneficial, becomes harmful when it is prolonged over time, leading to , aggravating the disease and encouraging its progression.

In the work just published, it was possible to identify a receptor known as P2X4 present in the that increases their anti-inflammatory potential in order to reduce the damage in multiple sclerosis and encourage the body's own repair responses. This experimental development was conducted using animal models of MS, thanks to which it was possible to discover that the drugs that activate this receptor improve the symptoms during the chronic phase of the disease when furthering the repair of the nervous tissue.

Dr. María Domercq of the UPV/EHU's Department of Neurosciences and who works at the ACHUCARRO centre for research in Leioa (Basque Country) says, "We are witnessing a discovery that is opening up a new channel of pharmacological development for the treatment of the progressive phase of multiple sclerosis, and with it we want to open a new door on improving the life quality of people who suffer ."


Explore further

Chemical compound produces beneficial inflammation, remyelination that could help treat MS

More information: Alazne Zabala et al, P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis, EMBO Molecular Medicine (2018). DOI: 10.15252/emmm.201708743
Journal information: EMBO Molecular Medicine

Citation: A molecular key for delaying the progression of multiple sclerosis is found (2018, July 23) retrieved 24 May 2019 from https://medicalxpress.com/news/2018-07-molecular-key-multiple-sclerosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
70 shares

Feedback to editors

User comments

Jul 30, 2018
I was on Copaxone, the first year was daily and later was 40 mg, 3 times a week. It didn't make a tremendous difference for me. I've tried therapy, but it is not helping. I was seeking something to help regain my life to be able to do things for myself. It is frustrating when it feels like nobody is trying to help you find some relief. March this year after reading a lot of positive reviews online about a Natural Herbal Gardens My primary physician suggested I started Natural herbal treatment, I ordered the herbal formula and I am glad to report the herbal formula worked effectively and there was no side effects, I had a total decline in symptoms, the joints pain, weakness and other symptoms stopped, my MS is totally REVERSED, Here

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more